Literature DB >> 26572148

Candida tropicalis Biofilms: Biomass, Metabolic Activity and Secreted Aspartyl Proteinase Production.

Melyssa Negri1,2, Sónia Silva3, Isis Regina Grenier Capoci2, Joana Azeredo1, Mariana Henriques1.   

Abstract

According to epidemiological data, Candida tropicalis has been related to urinary tract infections and haematological malignancy. Several virulence factors seem to be responsible for C. tropicalis infections, for example: their ability to adhere and to form biofilms onto different indwelling medical devices; their capacity to adhere, invade and damage host human tissues due to enzymes production such as proteinases. The main aim of this work was to study the behaviour of C. tropicalis biofilms of different ages (24-120 h) formed in artificial urine (AU) and their ability to express aspartyl proteinase (SAPT) genes. The reference strain C. tropicalis ATCC 750 and two C. tropicalis isolates from urine were used. Biofilms were evaluated in terms of culturable cells by colony-forming units enumeration; total biofilm biomass was evaluated using the crystal violet staining method; metabolic activity was evaluated by XTT assay; and SAPT gene expression was determined by real-time PCR. All strains of C. tropicalis were able to form biofilms in AU, although with differences between strains. Candida tropicalis biofilms showed a decrease in terms of the number of culturable cells from 48 to 72 h. Generally, SAPT3 was highly expressed. C. tropicalis strains assayed were able to form biofilms in the presence of AU although in a strain- and time-dependent way, and SAPT genes are expressed during C. tropicalis biofilm formation.

Entities:  

Keywords:  Artificial urine; Biofilm; Candida tropicalis; SAPT gene

Mesh:

Substances:

Year:  2015        PMID: 26572148     DOI: 10.1007/s11046-015-9964-4

Source DB:  PubMed          Journal:  Mycopathologia        ISSN: 0301-486X            Impact factor:   2.574


  39 in total

Review 1.  Candida biofilms on implanted biomaterials: a clinically significant problem.

Authors:  Gordon Ramage; José Pedro Martínez; José Luis López-Ribot
Journal:  FEMS Yeast Res       Date:  2006-11       Impact factor: 2.796

2.  Crystal violet staining to quantify Candida adhesion to epithelial cells.

Authors:  M Negri; V Gonçalves; S Silva; M Henriques; J Azeredo; R Oliveira
Journal:  Br J Biomed Sci       Date:  2010       Impact factor: 3.829

3.  In vitro biofilm activity of non-Candida albicans Candida species.

Authors:  Sónia Silva; Mariana Henriques; Rosário Oliveira; David Williams; Joana Azeredo
Journal:  Curr Microbiol       Date:  2010-04-17       Impact factor: 2.188

Review 4.  Relative frequency of albicans and the various non-albicans Candida spp among candidemia isolates from inpatients in various parts of the world: a systematic review.

Authors:  Matthew E Falagas; Nikos Roussos; Konstantinos Z Vardakas
Journal:  Int J Infect Dis       Date:  2010-08-24       Impact factor: 3.623

Review 5.  Candida infections of medical devices.

Authors:  Erna M Kojic; Rabih O Darouiche
Journal:  Clin Microbiol Rev       Date:  2004-04       Impact factor: 26.132

6.  Comparison of multiple methods for quantification of microbial biofilms grown in microtiter plates.

Authors:  Elke Peeters; Hans J Nelis; Tom Coenye
Journal:  J Microbiol Methods       Date:  2007-11-21       Impact factor: 2.363

7.  Real-time PCR expression profiling of genes encoding potential virulence factors in Candida albicans biofilms: identification of model-dependent and -independent gene expression.

Authors:  Heleen Nailis; Sona Kucharíková; Markéta Ricicová; Patrick Van Dijck; Dieter Deforce; Hans Nelis; Tom Coenye
Journal:  BMC Microbiol       Date:  2010-04-16       Impact factor: 3.605

8.  Uses and limitations of the XTT assay in studies of Candida growth and metabolism.

Authors:  D M Kuhn; M Balkis; J Chandra; P K Mukherjee; M A Ghannoum
Journal:  J Clin Microbiol       Date:  2003-01       Impact factor: 5.948

9.  Characteristics of Candida albicans biofilms grown in a synthetic urine medium.

Authors:  Priya Uppuluri; Hemamalini Dinakaran; Derek P Thomas; Ashok K Chaturvedi; Jose L Lopez-Ribot
Journal:  J Clin Microbiol       Date:  2009-09-30       Impact factor: 5.948

10.  Virulence Factors Contributing to Pathogenicity of Candida tropicalis and Its Antifungal Susceptibility Profile.

Authors:  Sachin C Deorukhkar; Santosh Saini; Stephen Mathew
Journal:  Int J Microbiol       Date:  2014-04-02
View more
  5 in total

1.  The Activities of Adhesion and Biofilm Formation by Candida tropicalis Clinical Isolates Display Significant Correlation with Its Multilocus Sequence Typing.

Authors:  Shuan Bao Yu; Wen Ge Li; Xiao Shu Liu; Jie Che; Jin Xing Lu; Yuan Wu
Journal:  Mycopathologia       Date:  2017-01-13       Impact factor: 2.574

2.  Virulence Factors and Antifungal Susceptibility Profile of C. tropicalis Isolated from Various Clinical Specimens in Alexandria, Egypt.

Authors:  Mohammed A El-Kholy; Ghada F Helaly; Ebtisam F El Ghazzawi; Gamal El-Sawaf; Sherine M Shawky
Journal:  J Fungi (Basel)       Date:  2021-04-29

Review 3.  The Basics of Bacteriuria: Strategies of Microbes for Persistence in Urine.

Authors:  Deepak S Ipe; Ella Horton; Glen C Ulett
Journal:  Front Cell Infect Microbiol       Date:  2016-02-08       Impact factor: 5.293

4.  Control of Cryptococcus Gattii Biofilms by an Ethanolic Extract of Cochlospermum Regium (Schrank) Pilger Leaves.

Authors:  Adriana A Almeida-Apolonio; Wellinton J Cupozak-Pinheiro; Vagner M Berres; Fabiana G S Dantas; Terezinha I E Svidzinski; Kelly M P Oliveira; Marilene R Chang
Journal:  ScientificWorldJournal       Date:  2018-06-06

5.  Microbiological and virulence aspects of Rhodotorula mucilaginosa.

Authors:  Isabele Carrilho Jarros; Flávia Franco Veiga; Jakeline Luiz Corrêa; Isabella Letícia Esteves Barros; Marina Cristina Gadelha; Morgana F Voidaleski; Neli Pieralisi; Raissa Bocchi Pedroso; Vânia A Vicente; Melyssa Negri; Terezinha Inez Estivalet Svidzinski
Journal:  EXCLI J       Date:  2020-05-27       Impact factor: 4.068

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.